Patient characteristics among R1 randomization arms
. | DNR arm . | IDA arm . | P value . |
---|---|---|---|
No. patients | 209 | 207 | NA |
Median age, y | 72 | 72 | .91 |
AML type, no. patients | |||
de novo AML | 179 | 174 | .68 |
post-MDS AML | 30 | 33 | |
Median WBC count, × 109/L | 5.5 | 5 | .69 |
Karyotype, no. patients | |||
Not done | 11 | 16 | .33 |
Failure | 36 | 14 | .001 |
Standard-risk | 137 | 153 | .07 |
High-risk | 25 | 24 | .99 |
. | DNR arm . | IDA arm . | P value . |
---|---|---|---|
No. patients | 209 | 207 | NA |
Median age, y | 72 | 72 | .91 |
AML type, no. patients | |||
de novo AML | 179 | 174 | .68 |
post-MDS AML | 30 | 33 | |
Median WBC count, × 109/L | 5.5 | 5 | .69 |
Karyotype, no. patients | |||
Not done | 11 | 16 | .33 |
Failure | 36 | 14 | .001 |
Standard-risk | 137 | 153 | .07 |
High-risk | 25 | 24 | .99 |
NA indicates not applicable.